Day: January 6, 2023

MONTVALE, N.J., Jan. 06, 2023 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) announced that the Company has been named one of America’s Most Responsible Companies by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider. Balchem has earned a ranking amongst this prestigious list of companies for the third consecutive year. America’s Most Responsible Companies were selected based on publicly available key performance indicators derived from CSR Reports, Sustainability Reports, and other reports as well as an independent survey. The KPIs focused on company performance in the environmental, social, and corporate governance areas, while the independent survey asked U.S. citizens about their perception of company activities related to corporate social responsibility. “As a company committed...

MONTREAL, Jan. 06, 2023 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood” or “the Company”) (TSX: FOOD), a leading Canadian online meal solutions company, will release its financial results for the first quarter of Fiscal 2023 on Tuesday, January 17, 2023, before markets open. Jonathan Ferrari, CEO, Neil Cuggy, President and COO, and Jonathan Roiter, CFO, will hold a conference call to review the results at 8:00 a.m. (ET) on the same day. In addition, Goodfood’s Annual General Meeting of Shareholders will also be held on Tuesday, January 17, 2023, at 10:00 a.m. (ET). The meeting will be held virtually through the virtual meeting platform of the TSX. Details of the Q1 Earnings Conference Call: When: January 17, 2023 at 8:00 a.m. ET Dial in number: 1 (888) 396-8049 or 1 (416) 764-8646 Conference call replay available until January...

AUSTIN, Texas, Jan. 06, 2023 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading Infrastructure and Environmental solutions provider, announced today that it was selected by the Georgia Department of Transportation’s (GDOT) Railroad Safety Program to provide Engineering & Design and Environmental services related to rail crossings owned by one of the largest Class 1 rail operators in the state. The contract has a maximum value of $15 million with an initial term of three years, and an option for a two-year extension. GDOT’s Railroad Safety Program mission is to identify, reduce and eliminate hazards at at-grade railroad crossings throughout the State through the installation of warning device equipment, crossing consolidation, and roadway and striping improvements to crossing...

CALGARY, Alberta, Jan. 06, 2023 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX: SFD; OTCQB: NSFDF) announces the grant of 2,050,000 incentive stock options at a price of $0.216 to employees, officers and directors. The incentive stock options will vest upon receipt of cash for SFD® services performed: 1/3 upon collection of US$6.5 million, 1/3 upon the collection of the next US$7.0 million and the final 1/3 upon collection of an additional US$7.5 million. The vesting milestones have been set to be consistent with our near term expectations for growth of the business, and are intended to retain and incentivize NXT’s dedicated and highly qualified team to achieve these targets. About NXT Energy Solutions Inc. NXT Energy Solutions Inc. is a Calgary-based technology company whose...

Hamsters infected with SARS-COV-2 and then treated with BiondVax’s inhaled anti-COVID-19 nanosized antibodies (NanoAbs) had over 30-times lower lung viral titer on average compared to those treated with inhaled placebo Result builds on recently announced data indicating NanoAb treatment led to significantly milder illness and faster recovery in comparison to the placebo group BiondVax’s NanoAbs are being formulated as a convenient self‑administered inhaled drug for treatment and potential prophylactic prevention of COVID-19   First-in-human Phase 1/2a clinical trial planned for 2023 The COVID-19 therapy is BiondVax’s first in a new pipeline of innovative alpaca-derived NanoAb therapies addressing diseases with large underserved medical needs and attractive commercial opportunities such as psoriasis and asthmaJERUSALEM, Jan. 06, 2023...

WAYNE, Pa., Jan. 06, 2023 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today is providing a corporate outlook for 2023. “2023 is setting up to be an incredibly exciting year for Aclaris with several important expected data read-outs for our two lead clinical programs, zunsemetinib (ATI-450) and ATI-1777,” stated Douglas Manion, M.D., Aclaris’ Chief Executive Officer and President. “In addition to these highly anticipated clinical milestones, we also are eager to progress the development of our earlier stage assets such as ATI-2138 for T cell mediated diseases and ATI-2231 for certain oncology indications,” continued Dr. Manion.  “Our research and development team also continues to identify and...

-Company To Focus on Preserving Cash to Fund Orderly Wind Down of Operations- -Company To Continue Work With Torreya Capital On Asset Monetization- DUBLIN, Ireland, Jan. 06, 2023 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV) today announced that, after an assessment of strategic options, its Board of Directors approved a plan to preserve cash in order to adequately fund an orderly wind down of the Company’s operations. As previously disclosed, the Company engaged Torreya Capital to facilitate the exploration of a range of strategic options, including potential in-licensing or out-licensing of commercial stage assets. While the Company continues to work with Torreya Capital on identifying and evaluating potential strategic options with the goal of maximizing shareholder value, the Company is currently focused on the...

GUANGZHOU, China, Jan. 06, 2023 (GLOBE NEWSWIRE) — LIZHI INC. (“LIZHI” or the “Company”) (NASDAQ: LIZI), an audio-based social and entertainment company, recently concluded another successful Voice Gala​​, which uplifts content creators in LIZHI’s audio community. The annual Voice Gala series of activities and competitions, which started in 2018 and is in its fifth year, is one of LIZHI’s major activities every year. Starting in late November 2022, the 2022 Voice Gala promotes collaboration and innovation among audio content creators, uncovers hidden potential, and rewards outstanding creators with an array of prizes, including the Honor of the Year award. ​​ At the same time, LIZHI weaves online interactive activities into the Voice Gala so that users can join in and participate – encouraging more user engagement and strengthening...